Orthofix Medical (OFIX): Market Cap to Revenue
Orthofix Medical Inc. (OFIX) relies on the production of bone stimulation systems and extremity surgery instruments. The current price-to-sales ratio on the GURU.Markets terminal displays a chart of the metric where the indicator value reaches 0.30. Growth potential is based on the merger with SeaSpine and synergy with clinics, as well as the systematic reduction of production waste and plastic in packaging.
Analytical breakdowns for Orthofix International (OFIX)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book value of equity indicators:
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Orthofix Medical Inc.|OFIX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Orthofix Corp|OFIX - Company Aggregate Debts|Debts to Book Capitalization Orthofix International|OFIX - Company Long-Term Debt|Company Short-Term Debt Orthofix|Intermediate Coverage Ratio orthofix.com
- earnings and multiples data:
OFIX - Net Profit|Expected Net Profit Orthofix Medical Inc.|OFIX - Price to Earnings Ratio|Forward Price to Earnings Multiple Orthofix Medical|OFIX - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Orthofix International|OFIX - Operating profit EBITDA|Net earnings per share for the last four quarters Orthofix|OFIX - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months orthofix.com|OFIX - Earnings per share growth in current year|Expected earnings per share growth for next year Orthofix Medical Inc.
- issuer revenue and sales details:
General company analysis:OFIX orthofix.com
To determine the fundamental value of Orthofix Medical Inc. (OFIX), an investor must compare market capitalization with actual sales volume. A P/S valuation analysis allows for the identification of an overbought asset by measuring the amount of value per unit of revenue, which is critically important during the integration with SeaSpine and the expansion of margins driven by the growth in elective surgeries in the US.
Competitors of Orthofix Medical Inc.
BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Bioventus Inc (BVS) - Price-to-Revenue Multiple|OrthoPediatrics - Market Cap to Revenue|P/S Multiple Treace Corp TMCI|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|xtantmedical.com (XTNT) - Price-to-Revenue Ratio|Price to Sales n1mtc.com (NMTC)|Price-to-Revenue Ratio Modular Medical Inc|MYO: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue COCH (Envoy Medical, Inc)|Market Cap to Sales Volume VVOS|P/S Multiple NVNO (enVVeno Medical)|Market Capitalization-to-Revenue Ratio SINT|TNON - Price-to-Revenue Ratio|Price to Sales ReWalk Robotics|AMIX: P/S Multiple|Price-to-Sales Ratio IVF (INVO Fertility Corp)|BBLG (Bone Biologics) - P/S Multiple|axonics.com (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (BIOLASE)|dynatronics.com - Market Cap to Revenue Ratio|Paragon 28 - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio INVO
